134 related articles for article (PubMed ID: 30737623)
21. Quantitative expression of the human kallikrein gene 9 (KLK9) in ovarian cancer: a new independent and favorable prognostic marker.
Yousef GM; Kyriakopoulou LG; Scorilas A; Fracchioli S; Ghiringhello B; Zarghooni M; Chang A; Diamandis M; Giardina G; Hartwick WJ; Richiardi G; Massobrio M; Diamandis EP; Katsaros D
Cancer Res; 2001 Nov; 61(21):7811-8. PubMed ID: 11691797
[TBL] [Abstract][Full Text] [Related]
22. Alteration and clinical relevance of PTEN expression and its correlation with survivin expression in epithelial ovarian tumors.
Sui L; Dong Y; Watanabe Y; Yamaguchi F; Sugimoto K; Tokuda M
Oncol Rep; 2006 Apr; 15(4):773-8. PubMed ID: 16525657
[TBL] [Abstract][Full Text] [Related]
23. Glycodelin in ovarian serous carcinoma: association with differentiation and survival.
Mandelin E; Lassus H; Seppälä M; Leminen A; Gustafsson JA; Cheng G; Bützow R; Koistinen R
Cancer Res; 2003 Oct; 63(19):6258-64. PubMed ID: 14559812
[TBL] [Abstract][Full Text] [Related]
24. Characterization of ovarian clear cell carcinoma using target drug-based molecular biomarkers: implications for personalized cancer therapy.
Li M; Li H; Liu F; Bi R; Tu X; Chen L; Ye S; Cheng X
J Ovarian Res; 2017 Feb; 10(1):9. PubMed ID: 28187748
[TBL] [Abstract][Full Text] [Related]
25. Expression and clinical role of antiapoptotic proteins of the bag, heat shock, and Bcl-2 families in effusions, primary tumors, and solid metastases in ovarian carcinoma.
Elstrand MB; Kleinberg L; Kohn EC; Tropé CG; Davidson B
Int J Gynecol Pathol; 2009 May; 28(3):211-21. PubMed ID: 19620938
[TBL] [Abstract][Full Text] [Related]
26. Cytoplasmic FOXP1 expression is correlated with ER and calpain II expression and predicts a poor outcome in breast cancer.
Yu BH; Li BZ; Zhou XY; Shi DR; Yang WT
Diagn Pathol; 2018 May; 13(1):36. PubMed ID: 29848352
[TBL] [Abstract][Full Text] [Related]
27. Expression level of Wilms tumor 1 (WT1) protein has limited prognostic value in epithelial ovarian cancer: from the Danish "MALOVA" ovarian cancer study.
Høgdall EV; Christensen L; Kjaer SK; Blaakaer J; Christensen IJ; Gayther S; Jacobs IJ; Høgdall CK
Gynecol Oncol; 2007 Aug; 106(2):318-24. PubMed ID: 17540436
[TBL] [Abstract][Full Text] [Related]
28. [Clinicopathologic study and immunohistochemistry comparison of Pax2, p53 and Ki-67 in low- and high-grade ovarian serous carcinomas].
Shen XX; Yu L; Bi R; Yang WT
Zhonghua Bing Li Xue Za Zhi; 2011 Aug; 40(8):511-6. PubMed ID: 22169637
[TBL] [Abstract][Full Text] [Related]
29. The prognostic value of Stathmin-1, S100A2, and SYK proteins in ER-positive primary breast cancer patients treated with adjuvant tamoxifen monotherapy: an immunohistochemical study.
Golouh R; Cufer T; Sadikov A; Nussdorfer P; Usher PA; Brünner N; Schmitt M; Lesche R; Maier S; Timmermans M; Foekens JA; Martens JW
Breast Cancer Res Treat; 2008 Jul; 110(2):317-26. PubMed ID: 17874182
[TBL] [Abstract][Full Text] [Related]
30. Clinicopathologic analysis of low-stage sporadic ovarian carcinomas: a reappraisal.
Karamurzin Y; Leitao MM; Soslow RA
Am J Surg Pathol; 2013 Mar; 37(3):356-67. PubMed ID: 23282975
[TBL] [Abstract][Full Text] [Related]
31. Defective expression of Protein 4.1N is correlated to tumor progression, aggressive behaviors and chemotherapy resistance in epithelial ovarian cancer.
Xi C; Ren C; Hu A; Lin J; Yao Q; Wang Y; Gao Z; An X; Liu C
Gynecol Oncol; 2013 Dec; 131(3):764-71. PubMed ID: 23994105
[TBL] [Abstract][Full Text] [Related]
32. HOXB8 expression in ovarian serous carcinoma effusions is associated with shorter survival.
Stavnes HT; Holth A; Don T; Kærn J; Vaksman O; Reich R; Trope' CG; Davidson B
Gynecol Oncol; 2013 May; 129(2):358-63. PubMed ID: 23438671
[TBL] [Abstract][Full Text] [Related]
33. Expression of beta-tubulin isotypes in human primary ovarian carcinoma.
Ohishi Y; Oda Y; Basaki Y; Kobayashi H; Wake N; Kuwano M; Tsuneyoshi M
Gynecol Oncol; 2007 Jun; 105(3):586-92. PubMed ID: 17343904
[TBL] [Abstract][Full Text] [Related]
34. [Survivin expression in ovarian carcinoma].
Yin RT; Peng ZL; Yang KX; Kang DY
Sichuan Da Xue Xue Bao Yi Xue Ban; 2006 Mar; 37(2):215-7, 233. PubMed ID: 16608078
[TBL] [Abstract][Full Text] [Related]
35. Caspase-3 and caspase-8 expression in breast cancer: caspase-3 is associated with survival.
Pu X; Storr SJ; Zhang Y; Rakha EA; Green AR; Ellis IO; Martin SG
Apoptosis; 2017 Mar; 22(3):357-368. PubMed ID: 27798717
[TBL] [Abstract][Full Text] [Related]
36. Calpain-1 expression is associated with relapse-free survival in breast cancer patients treated with trastuzumab following adjuvant chemotherapy.
Storr SJ; Woolston CM; Barros FF; Green AR; Shehata M; Chan SY; Ellis IO; Martin SG
Int J Cancer; 2011 Oct; 129(7):1773-80. PubMed ID: 21140455
[TBL] [Abstract][Full Text] [Related]
37. Microtubule-associated protein 4 is an important regulator of cell invasion/migration and a potential therapeutic target in esophageal squamous cell carcinoma.
Jiang YY; Shang L; Shi ZZ; Zhang TT; Ma S; Lu CC; Zhang Y; Hao JJ; Shi C; Shi F; Xu X; Cai Y; Jia XM; Zhan QM; Wang MR
Oncogene; 2016 Sep; 35(37):4846-56. PubMed ID: 26876215
[TBL] [Abstract][Full Text] [Related]
38. Clinical significance of nuclear expression of spleen tyrosine kinase (Syk) in gastric cancer.
Nakashima H; Natsugoe S; Ishigami S; Okumura H; Matsumoto M; Hokita S; Aikou T
Cancer Lett; 2006 May; 236(1):89-94. PubMed ID: 15993535
[TBL] [Abstract][Full Text] [Related]
39. Nuclear expression of apurinic/apyrimidinic endonuclease increases with progression of ovarian carcinomas.
Tanner B; Grimme S; Schiffer I; Heimerdinger C; Schmidt M; Dutkowski P; Neubert S; Oesch F; Franzen A; Kölbl H; Fritz G; Kaina B; Hengstler JG
Gynecol Oncol; 2004 Feb; 92(2):568-77. PubMed ID: 14766249
[TBL] [Abstract][Full Text] [Related]
40. The expression of DBC1/CCAR2 is associated with poor prognosis of ovarian carcinoma.
Cho D; Park H; Park SH; Kim K; Chung M; Moon W; Kang M; Jang K
J Ovarian Res; 2015 Feb; 8():2. PubMed ID: 25823848
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
